Eddy S Yang Selected Research

(+)-JQ1 compound

1/2022	The BET Inhibitor JQ1 Potentiates the Anticlonogenic Effect of Radiation in Pancreatic Cancer Cells.
7/2021	The BET Inhibitor JQ1 Augments the Antitumor Efficacy of Gemcitabine in Preclinical Models of Pancreatic Cancer.
6/2019	The BET inhibitor JQ1 attenuates double-strand break repair and sensitizes models of pancreatic ductal adenocarcinoma to PARP inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eddy S Yang Research Topics

Disease

65	Neoplasms (Cancer) 11/2022 - 01/2002
13	Breast Neoplasms (Breast Cancer) 11/2022 - 11/2008
11	Prostatic Neoplasms (Prostate Cancer) 10/2019 - 01/2002
10	Head and Neck Neoplasms (Head and Neck Cancer) 01/2021 - 07/2009
9	Squamous Cell Carcinoma of Head and Neck 01/2021 - 06/2011
8	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 09/2012
7	Carcinoma (Carcinomatosis) 01/2020 - 09/2014
6	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020 - 06/2011
5	Triple Negative Breast Neoplasms 08/2021 - 01/2021
5	Carcinogenesis 01/2020 - 07/2013
5	Adenocarcinoma 06/2019 - 03/2015
4	Body Weight (Weight, Body) 01/2020 - 01/2017
2	Hypoxia (Hypoxemia) 02/2022 - 01/2022
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 07/2021
2	Colonic Neoplasms (Colon Cancer) 01/2022 - 08/2010
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 01/2016
2	Melanoma (Melanoma, Malignant) 01/2021 - 05/2020
2	Ascites 01/2020 - 12/2016
2	Weight Loss (Weight Reduction) 01/2020 - 10/2017
2	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 06/2019 - 12/2015
2	Lung Neoplasms (Lung Cancer) 03/2017 - 03/2015
2	Glioblastoma (Glioblastoma Multiforme) 06/2014 - 06/2012
2	Brain Neoplasms (Brain Tumor) 01/2011 - 05/2009
1	Body Weight Changes 07/2021
1	Deglutition Disorders (Dysphagia) 01/2021
1	Opioid-Related Disorders (Opiate Addiction) 01/2021
1	Pain (Aches) 01/2021

Drug/Important Bio-Agent (IBA)

17	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2021 - 01/2011
12	Proteins (Proteins, Gene)FDA Link 10/2021 - 08/2010
10	DNA (Deoxyribonucleic Acid)IBA 02/2022 - 06/2012
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2011
8	Cetuximab (Erbitux)FDA Link 01/2021 - 06/2009
8	veliparibIBA 01/2021 - 01/2011
8	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 12/2020 - 01/2011
6	Phosphotransferases (Kinase)IBA 01/2020 - 06/2014
5	Pharmaceutical PreparationsIBA 01/2022 - 08/2007
5	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 08/2010
4	Gemcitabine FDA Link 08/2021 - 01/2018
4	Messenger RNA (mRNA)IBA 01/2021 - 04/2015
4	olaparibIBA 12/2020 - 09/2012
4	ErbB Receptors (EGF Receptor)IBA 01/2020 - 11/2008
4	AndrogensIBA 02/2017 - 01/2002
3	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 02/2022 - 01/2011
3	(+)-JQ1 compoundIBA 01/2022 - 06/2019
3	Small Interfering RNA (siRNA)IBA 01/2022 - 06/2011
3	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2016
3	prexasertibIBA 01/2021 - 01/2017
3	Histones (Histone)IBA 01/2021 - 01/2014
3	CateninsIBA 01/2020 - 12/2016
3	Myristoylated Alanine-Rich C Kinase SubstrateIBA 03/2017 - 06/2012
3	Poly (ADP-Ribose) Polymerase-1IBA 01/2017 - 11/2013
3	Vitamin D FDA LinkGeneric 12/2015 - 01/2002
2	Trastuzumab (Herceptin)FDA Link 02/2022 - 01/2018
2	fluoromisonidazoleIBA 02/2022 - 01/2022
2	Biological ProductsIBA 01/2022 - 01/2016
2	Immunoconjugates (Immunoconjugate)IBA 08/2021 - 01/2021
2	Maytansine (Maitansine)IBA 08/2021 - 07/2021
2	EnzymesIBA 01/2021 - 11/2013
2	PlatinumIBA 01/2020 - 01/2013
2	Prostate-Specific Antigen (Semenogelase)IBA 01/2019 - 04/2018
2	Niclosamide FDA Link 10/2018 - 12/2016
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 03/2017 - 01/2011
2	Peptides (Polypeptides)IBA 03/2017 - 03/2015
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 07/2004 - 11/2003
2	Cholecalciferol (Vitamin D3)FDA Link 11/2003 - 01/2002
1	Hormones (Hormone)IBA 11/2022
1	Interleukin-2 (IL2)IBA 02/2022
1	TH 302IBA 01/2022
1	CytokinesIBA 01/2022
1	baysilon (polydimethylsiloxane)IBA 01/2022
1	N-vinyl-2-pyrrolidinoneIBA 01/2022
1	Coloring Agents (Dyes)IBA 01/2022
1	Monoclonal AntibodiesIBA 08/2021
1	CholesterolIBA 07/2021
1	theasinensin AIBA 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	5-hydroxymethylcytosineIBA 01/2021
1	Lapatinib (GW572016)FDA Link 01/2021
1	Everolimus FDA Link 01/2021
1	LipidsIBA 01/2021
1	BNC 105PIBA 01/2021
1	histone H3 trimethyl Lys4IBA 01/2021
1	Oxycodone (Oxycontin)FDA LinkGeneric 01/2021
1	phosphoserine phosphataseIBA 01/2021
1	Serine (L-Serine)FDA Link 01/2021
1	human ERBB2 proteinIBA 12/2020
1	SCH772984IBA 05/2020
1	BMS 754807IBA 05/2020
1	Histone Acetyltransferases (Histone Acetyltransferase)IBA 05/2020

Therapy/Procedure

27	Therapeutics 01/2022 - 08/2007
14	Radiotherapy 02/2022 - 06/2011
5	Drug Therapy (Chemotherapy) 08/2021 - 07/2009
4	Precision Medicine 01/2022 - 10/2015
2	Neoadjuvant Therapy 11/2022 - 01/2018
2	Caloric Restriction 01/2020 - 10/2017
1	Immunotherapy 01/2022
1	Analgesia 01/2021
1	Gastrostomy 01/2021
1	Microspheres (Microsphere) 01/2021
1	Pain Management 01/2021